Clinical Screening · PHQ-9 (Kroenke, Spitzer & Williams, 2001)

Free Depression Test (PHQ-9)

Answer thinking about the past 2 weeks. The standard published PHQ-9 — the most widely used depression screen in primary care worldwide. Instant severity band, optional functional-impact item, and immediate crisis-resource surfacing on any non-zero answer to item 9.

Questions

9 items

Instrument

PHQ-9 (2001)

Time

2–4 min

Privacy

100% local

Screening disclaimer: The PHQ-9 is a self-report tool, not a clinical diagnosis. If you are in crisis, please contact a crisis line — full international list below the test.

Over the last 2 weeks, how often have you been bothered by any of the following problems? Answer based on your actual recent experience, not your usual self.

Question 1 of 90% complete

Little interest or pleasure in doing things

Depression by the numbers

Data from NIMH, WHO, and meta-analyses of PHQ-9 performance.

8.3%

US adults — past-year major depression

NIMH 2021

21%

Lifetime prevalence — MDD

Kessler et al.

88%

PHQ-9 sensitivity at cutoff ≥ 10

Kroenke et al. 2001

60–70%

Respond to first-line treatment (CBT or SSRI)

Cuijpers et al.

Methodology & sources

Methodology & sources

Based on
The PHQ-9 (Patient Health Questionnaire-9) — the standard published 9-item depression screen from the PRIME-MD family.
Developed by
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. Original PRIME-MD PHQ paper: Spitzer, Kroenke & Williams (1999), JAMA, 282(18), 1737–1744.
Validated in
The PHQ-9 is the most widely used depression screen in primary care worldwide, validated across 70+ languages and dozens of populations. Cronbach α typically 0.86–0.89; sensitivity and specificity around 88% at cutoff ≥ 10 for Major Depressive Disorder.
Our adaptation
Uses the published PHQ-9 verbatim — item wordings, 'over the last 2 weeks' framing, and the standard 0–3 frequency scoring (sum range 0–27). Item 10 (functional impact) is shown separately and not added to the total, matching the published instrument. The PHQ-9 was released by Pfizer without licensing restriction — free for clinical, research, and educational use with attribution.

How to read your PHQ-9 score

The standard severity bands (Kroenke, Spitzer & Williams, 2001). Cutoffs are stable across the international literature and are the numbers primary care uses for treatment-planning decisions.

0–4

Minimal

No clinical concern indicated. Symptom load within typical range.

5–9

Mild

Watchful waiting; lifestyle interventions often sufficient. Re-screen in 2–4 weeks.

10–14

Moderate

Clinical threshold for Major Depressive Disorder. Discuss with a clinician.

15–19

Moderately severe

Active treatment warranted. Combined CBT + SSRI is the evidence-based first-line.

20–27

Severe

Prompt clinical contact recommended. Combined treatment plus closer follow-up.

Item 9 — the most important single signal

Any non-zero answer to item 9 (thoughts of being better off dead or of hurting yourself) warrants same-day contact with a clinician or crisis line, regardless of the total score. Standard PHQ-9 clinical practice surfaces item 9 as a stand-alone safety signal — not because the thoughts mean imminent danger, but because they are the marker for which immediate professional support is the appropriate response.

What clinical depression looks like in real life

Three composite vignettes drawn from common depressive presentations. Names and details are illustrative.

The grey weather that doesn't lift

Mara has felt this way for six years. Not crying — just flat. Work gets done. Friends are seen. The internal volume is turned down on everything: meals, sex, the music she used to love. She keeps screening it out as 'just my personality.' The PHQ-9 says 13. Her GP says 'persistent depressive disorder.' She has never heard those words before, and they are a relief.

The 4 AM wake-up

Tom wakes at 4 AM and can't get back to sleep. His chest is heavy. He's exhausted by noon. He's missed three deadlines this month, which is unlike him. His appetite has been off for weeks. He's not 'sad' exactly — he's somewhere worse than sad. The PHQ-9 says 18. He had been telling himself it would lift on its own.

The high-functioning depressive

Anna runs a team of 14 and has just been promoted. Her colleagues describe her as composed and reliable. Privately, she has had a recurring thought for the past month that her family would be better off without her. She has no plan and no intent — but the thought arrives every few days. PHQ-9 total: 14. Item 9: 'Several days.' Item 9 is the result that matters most.

How depression is treated

Depression is one of the most genuinely treatable conditions in mental health. Most people respond to the first or second evidence-based intervention tried.

First-line treatments

  • ✓ CBT (Cognitive-Behavioural Therapy)
  • ✓ Behavioural Activation (BA)
  • ✓ Interpersonal Therapy (IPT)
  • ✓ SSRIs / SNRIs for moderate–severe
  • ✓ CBASP for chronic / persistent depression

Evidence-supported adjuncts

  • ✓ Aerobic exercise (moderate-effect evidence)
  • ✓ Sleep regularity
  • ✓ Bright-light therapy (esp. seasonal pattern)
  • ✓ Reduced alcohol intake
  • ✓ Social re-engagement

Persistent (chronic) depression needs a different timeline

If your depression has lasted two years or more (Persistent Depressive Disorder), use the words "persistent" or "chronic" explicitly when you see a clinician. PDD responds best to longer courses of combined pharmacotherapy plus structured psychotherapy (CBASP is specifically designed for chronic depression); the 12-16-session protocols calibrated to acute MDD often aren't long enough.

Further reading & resources

Curated starting points if you want to go deeper than this page.

If you're in distress — reach out now

This screen is for self-reflection — it can't replace talking to a real person. If you're having thoughts of suicide, self-harm, or are in a crisis right now, please contact a hotline. It's free, confidential, and someone is always there.

Source, citation & methodology

Free public-use instrument
Instrument:
PHQ-9Patient Health Questionnaire-9
Original authors:
Kroenke, K., Spitzer, R. L., & Williams, J. B. W.
Year:
2001
Published in:
Journal of General Internal Medicine, 16(9), 606–613 (PHQ-9 validity paper); JAMA, 282(18), 1737–1744 (Spitzer, Kroenke & Williams, 1999 — original PRIME-MD PHQ).
Source link:
https://www.phqscreeners.com/select-screener
Mindshape adaptation:
Uses the standard published 9-item PHQ-9 with verbatim wordings, 'over the last 2 weeks' framing, and the standard 0–3 frequency scoring (sum range 0–27). Item 10 (functional impact) is displayed separately, not summed. The PHQ-9 was released by Pfizer without restriction — free for clinical, research, and educational use with attribution. Item 9 (suicidal ideation) triggers immediate crisis-resource surfacing regardless of total score, per standard clinical-safety practice.
Adaptation version:
v1.0 · last reviewed 2026-05-23

Clinical advisor program: onboarding

Mindshape is currently onboarding a named licensed clinical reviewer for ongoing review of every screening adaptation on this site. Until that arrangement is finalized and the reviewer's credentials are published here, treat every instrument-based screen as an educational adaptation of the source instrument cited below — useful for self-reflection, never as a clinical diagnosis. Source-instrument citations and adaptation version numbers are listed on each screen and in our full methodology. About this program

See the full Mindshape methodology page for every screen, every source, and every version stamp on one document.

Frequently asked questions

What is the PHQ-9?+

The Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report depression screen developed by Kurt Kroenke, Robert Spitzer, and Janet Williams as part of the PRIME-MD primary-care assessment system. The original validation paper appeared in JAMA in 1999 (Spitzer, Kroenke & Williams) and the standalone PHQ-9 validity paper in the Journal of General Internal Medicine in 2001 (Kroenke, Spitzer & Williams). It is the most widely used depression screen in primary care worldwide. It asks how often, over the past two weeks, you have been bothered by each of the nine DSM-5 depressive symptoms. Total score ranges from 0 to 27, with established severity bands at 5 (mild), 10 (moderate), 15 (moderately severe), and 20 (severe). At the cutoff ≥ 10, the PHQ-9 has sensitivity and specificity around 88% for major depressive disorder.

Is this a diagnosis?+

No. The PHQ-9 is a screening instrument, not a diagnostic interview. A formal diagnosis of Major Depressive Disorder or Persistent Depressive Disorder requires a clinician — typically a GP, psychologist, or psychiatrist — to interview you, rule out medical and substance-related causes, and apply DSM-5 criteria in full. A high PHQ-9 score is the signal that this conversation would be informative. Conversely, a low PHQ-9 score doesn't entirely rule out depression — particularly persistent depressive disorder, where the chronicity can lead to under-endorsement of items because the symptoms feel like baseline rather than illness.

What if I score high?+

At PHQ-9 ≥ 10 the standard primary-care recommendation is to discuss the result with a clinician — your GP first if you're in the UK, a psychologist or psychiatrist if you have direct access. Bring the actual score to the appointment; the PHQ-9 is the number primary care uses to guide treatment planning. At moderate-to-severe scores (15+), combined CBT or IPT plus an SSRI is the evidence-based first-line treatment. At any score, if you answered anything other than 'Not at all' to item 9 (thoughts of being better off dead or of hurting yourself), please contact a clinician or crisis line — 988 in the US/Canada, 116 123 in the UK/Ireland (Samaritans), 13 11 14 in Australia (Lifeline), 112 in the EU, findahelpline.com worldwide.

How long does the depression test take?+

The PHQ-9 takes most people 2–4 minutes. It is 9 items on a 4-point scale ('not at all', 'several days', 'more than half the days', 'nearly every day'), all anchored to the past 2 weeks, plus one optional functional-impact item that is displayed alongside the result but not added to the score.

Is it free and private?+

Yes. The PHQ-9 itself was released by Pfizer without licensing restrictions — it is free for clinical, research, and educational use. The Mindshape implementation is free, requires no sign-up, and runs in your browser. Your answers and result stay local unless you choose to save them to a Mindshape account, in which case they are encrypted at rest. No third-party trackers or affiliate networks see your responses.

When should I see a professional?+

Any PHQ-9 score ≥ 10 is the conventional primary-care cutoff for considering active treatment. Score ≥ 15 typically warrants a referral to a psychologist or psychiatrist within 1–2 weeks. Score ≥ 20 warrants prompt clinical attention. Independent of the total score, any non-zero answer on item 9 (suicidal ideation) warrants same-day contact with a clinician or crisis line — this is the most important single signal the PHQ-9 produces. If depression has been present for two years or more (persistent depressive disorder), the chronicity itself is worth flagging directly to the clinician, because treatment planning shifts.

What's the difference between depression and just feeling sad?+

Sadness is a normal emotional response to loss, disappointment, or difficulty — it is bounded in time, has a clear referent, and naturally resolves as circumstances change or the person processes the event. Depression is a clinical syndrome: persistent low mood and/or loss of interest lasting at least two weeks (for MDD) or two years (for PDD), accompanied by changes in sleep, appetite, energy, concentration, self-worth, psychomotor activity, and sometimes thoughts of death. Depression often has no specific referent — the low mood is there even when nothing has 'caused' it. It does not resolve simply by waiting. The PHQ-9 captures the difference by asking about frequency over the past two weeks across the nine core symptoms — sadness alone, even significant sadness, will not produce a high PHQ-9 score; clinical depression typically does.